—
ROSEAU, Commonwealth of Dominica, June 12ROSEAU, Commonwealth of Dominica, June 12 /PRNewswire/ -- Neuftec Limited, the proprietor of the original nano-particulate cerium Oxide fuel catalyst technology, today commenced patent infringement litigation in the UK against Oxonica Energy Limited, a wholly owned subsidiary of Oxonica PLC . The proceedings, issued in the High Court of Justice, allege infringement of Neuftec's European patent.
The proceedings seek an injunction against Oxonica as well as damages in relation to product already sold and delivery up or destruction of all articles that would infringe Neuftec's European patent.
Oxonica and its legal advisors have previously made statements on at least two occasions that they have no intention of dealing with products that infringe any of Neuftec's issued patents. However, despite these statements it is with regret that this is the second time, to the best of Neuftec's knowledge, that Oxonica has infringed its granted patents.
The first infringement came in May 2007 when it came to Neuftec's knowledge that Oxonica infringed the claims of Neuftec's Australian patent by collecting a shipment of Envirox without the knowledge, consent or authorization of Neuftec. This stock is estimated by Neuftec to have a resale value of approximately US$1.8 million and cannot be used or sold without Neuftec's permission. It has been stored in a warehouse in Australia since March 2007.
The latest alleged infringement occurred when Oxonica shipped Envirox formulations to Italy for use in Italian Government laboratory emission testing.
Neuftec is continuing it's investigations with customers, distributors & agents of Oxonica to determine the extent of the alleged infringement
Neuftec is represented in these proceedings by Watson, Farley & Williams LLP & Mr. Mark Platts-Mills QC of 8 New Square, London.
About Neuftec
Neuftec is a research & development company that owns patents in the fuel catalyst technology sector used in the production of the first version of EnviroxTM (2001-2007) that was manufactured by Advanced Nanotechnology ("ANO") of Australia under a manufacturing licence granted by Oxonica with authorization from Neuftec.
On 29 February 2008, IP Australia issued a re-examination report in respect of Neuftec's Australian patent. The patent had been issued in 2006 with 10 claims. In the re-examination report, IP Australia confirmed the patentability of the 10 claims as originally granted in 2006 in re-examination proceedings initiated by Oxonica.
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
